Medical Cyclotron Market

Segmentation By Product (AVF Cyclotron and Ring Cyclotron); By Energy (10-12 MeV, 16-18 MeV, 19-24 MeV and 24 MeV) and By End User (Specialized Clinics, Hospital, Pharmaceutical Companies and Research Laboratories) – Global Demand Analysis & Opportunity Outlook 2028

Buy Now
Report ID: 1112 | Published On: Feb 07, 2023
Request Free Sample Copy

Growth Drivers

Rising Cases of Cancer and Increasing Demand for Nuclear Scans to Boost the Market Growth

Lifestyle changes such as smoking and excess consumption of tobacco are the factors resulting in rise in cancer prevalence among majority of the population. According to the International Agency for Research on Cancer (IARC), in 2018, there were about 17 million new cancer cases and 9.5 million deaths due to cancer. Since there is a demand for accurate diagnosis of cancer at an early stage owing to increase in cancer awareness among the people, the demand for medical cyclotron is high. This is anticipated to significantly expand the medical cyclotron market. 


Advancement in Medical Imaging Technologies to Drive the Market Growth

The advancement in healthcare technology all over the world is improving at a fast pace owing to the increasing number of cases of various medical problems. As per the World Nuclear Association, the global radioisotope market was valued at $9.6 billion in 2016 and it is expected to reach about $17 billion by 2021. This results in the inclination towards advanced diagnostic methods like nuclear scans and growing acceptance of PET medical accelerators for the treatment of cancer. On the back of these, the market is predicted to grow over the forecast period. 


High Costs and Regulatory Constraints to Hamper the Market Growth

Factors such as high maintenance and operating costs associated with the cyclotron equipment coupled with the strict government regulations to be used in commercial purpose negatively affect the market growth. Also, lack of expertise to operate cyclotrons is estimated to hinder the growth of medical cyclotron market in the future.

Get more information on this report: Request Sample PDF

Market Size and Forecast

Increasing number of cancer patients and wide-scale applications of medical cyclotrons in production of medical isotopes coupled with its increased efficiency in the treatment of cancer are some of the significant factors boosting the market growth. The medical cyclotron market is anticipated to record a significant CAGR over the forecast period, i.e., 2020-2028. The market is segmented by energy into 10-12 MeV, 16-18 MeV, 19-24 MeV and 24 MeV. Among these segments, the segment for 16-18 MeV is anticipated to hold the leading share in the market on account of its small size compared to other particle accelerators along with the rise in demand for nuclear scans in hospitals owing to increasing incidence rate of cancer. Further, these cyclotrons are also required in universities and local industrial radionuclide plants. The 19-24 MeV based energy segment, on the other hand, is anticipated to grow at the highest rate in the medical cyclotron market as a result of its wide scale application in production of SPECT and PET radioisotopes used for medical researches. Additionally, they are the most cost-effective and best suited for diagnostic of patients and radio-pharmaceutical commercial plants.

Market Segmentation

Our in-depth analysis of the medical cyclotron market includes the following segments:

By Product

  • AVF Cyclotron
  • Ring Cyclotron

By Energy

  • 10-12 MeV
  • 16-18 MeV
  • 19-24 MeV
  • 24 MeV

By End User

  • Specialized Clinics
  • Hospital
  • Pharmaceutical Companies
  • Research Laboratories

By Region

On the basis of regional analysis, the medical cyclotron market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market for medical cyclotron in North America is anticipated to hold the largest share in the market on account of presence of leading market players in the region which manufacture and market medical cyclotrons. Moreover, soaring demand for nuclear scans owing to rise in cases of cancer and increasing capital investments in healthcare infrastructure further increases the product demand. The market in Asia Pacific region is predicted to grow at the highest rate during the forecast period as a result of increasing demand for cost-effective diagnosis owing to high awareness of cancer related disease among the people. The advancement in healthcare infrastructure like easy availability of radioactive tracers in the region, especially in countries such as China and Japan further raise the demand for medical cyclotron market.

The medical cyclotron market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis.
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis.

Get more information on this report: Request Sample PDF

Top Featured Companies Dominating the Market

In The News

  • April 2022: IBSRELA the first and only NHE3 inhibitor for the treatment of irritable bowel syndrome with constipation (IBS-C) in adults, has been made available by the biopharmaceutical company Ardelyx. The first Ardelyx product to receive approval from the US Food and Drug Administration is IBSRELA.
  • March 2022: Indegene a provider of technology-driven healthcare solutions, & meta Me Health, a maker of Regulora and a Prescription Digital Therapeutics (PDT) business, teamed up to offer Regulora as a remedy for irritable bowel syndrome-related stomach pain (IBS).

Global Economic Impact

Request Insights
Despite Inflation & Fearing Recession, Businesses Across the Globe Expected to Do Better in 2023:

In 2023, market players might incur losses due to huge gap in currency translation followed by contracting revenues, shrinking profit margins & cost pressure on logistics and supply chain.
Controlling Inflation has become the first priority for global economies from last quarter of 2022 and to be followed in 2023. With skewed economic situations, rise in interest rate by governments to control spending and inflation, spiked oil and gas prices, high inflation, geo-political issues including U.S. & China trade war, Russia-Ukraine conflict to intensify the global economic issues.
The interest rates in the U.S. may be less sensitive in 2023 as compared to 2022; sigh of relief for businesses. Positive business sentiments, healthy business balance sheets, growth in construction spending (private construction value in 2022 stood at $1,429.2 billion, 11.7 percent (±1.0 percent) above the $1,279.5 billion spent in 2021, Residential construction in 2022 was $899.1 billion, up by 13.3 percent (±2.1 percent) from $793.7 billion in 2021, non-residential construction touched $530.1 billion, 9.1 percent (±1.0 percent) above the $485.8 billion in 2021.) showcases minimal impact of recession in the country.
Similarly, spiked spending in the European and major Asia economics including, India, China & Japan to showcase less impact on the global demand.

Let Us Hear About Your Requirements:

Submit Your Request For Proposal (RFP)

Request Research Report Sample